Ticker
PRPHCompany Name
PROPHASE LABS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | -48.06% | $ 13.58M | $ 6.53M |
3/31/2025 | -79.79% | $ 13.63M | $ 10.87M |
12/31/2024 | -44.88% | $ 16.92M | $ 7.59M |
9/30/2024 | -25.15% | $ 18.38M | $ 4.62M |
6/30/2024 | -12.21% | $ 47.7M | $ 5.82M |
3/31/2024 | -1.2% | $ 96.35M | $ 1.15M |
12/31/2023 | 4.08% | $ 116.75M | $ -4.77M |
9/30/2023 | 10.59% | $ 81.83M | $ -8.66M |
6/30/2023 | 12.53% | $ 103.6M | $ -12.98M |
3/31/2023 | 10.57% | $ 136.26M | $ -14.4M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for PROPHASE LABS INC is calculated as follows: (-1 * CF - Equity [ $ 0 ]) / Market Cap [ $ 85.99M ]
(=) Buyback Yield [ 0% ]
Minimum
Mar 31, 2025
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.43% |
average | 0.64% |
median | 0.01% |
std | 2.71% |